Are you Dr. Langman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Summary
- Dr. Eun Langman, MD is a board certified radiologist in Durham, North Carolina. She is currently licensed to practice medicine in North Carolina. She is affiliated with Duke Raleigh Hospital.
Education & Training
Duke University HospitalResidency, Radiology-Diagnostic, 2010 - 2014
Mount Auburn HospitalResidency, Internal Medicine, 2009 - 2010
Duke University School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2010 - 2025- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- Subcutaneous Staining of the Breast from Superparamagnetic Iron Oxide Nanoparticle Tracer Injection.Victoria A Wells, Eun L Langman
Journal of Breast Imaging. 2024-11-23 - Editorial Comment: Expanding the Arsenal of Minimally Invasive Treatments Available for Early-Stage Breast Cancers.Eun L Langman
AJR. American Journal of Roentgenology. 2024-05-01 - 1 citationsNow or Later? Patient Satisfaction and Anxiety Among Women Undergoing Breast Biopsies Performed the Same Day as Recommended Versus a Later Day.Lars J Grimm, Rebecca A Shelby, Stamatia V Destounis, Emily E Knippa, Eun L Langman
Journal of the American College of Radiology. 2024-03-01
Authored Content
- Patient Perceptions of Breast Cancer Risk in Imaging-Detected Low-Risk Scenarios and Thresholds for Desired Intervention: A Multi-Institution SurveyMarch 2018
- Patient Perceptions of Breast Cancer Risk in Imaging-Detected Low-Risk Scenarios and Thresholds for Desired Intervention: A Multi-Institution SurveyMarch 2018
Press Mentions
Editorial Comment: Expanding the Arsenal of Minimally Invasive Treatments Available for Early-Stage Breast CancersMay 1st, 2024
